Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Accuray reports Q1 EPS (10c), consensus (4c) » 16:30
11/03/21
11/03
16:30
11/03/21
16:30
ARAY

Accuray

$5.51 /

+0.14 (+2.61%)

Reports Q1 revenue…

Reports Q1 revenue $107.4M, consensus $93.86M. "By any measure, our Q1 performance was a very strong start to our FY22 fiscal year. Q1 revenue of $107.4M represents the largest Q1 revenue that Accuray has ever recorded. Our performance reflects the visible impact of the investments in innovation we have made to our product portfolio, how those new technologies are being received by customers across the world and a laser-like focus on commercial execution, all of which are driving accelerated revenue growth in our business," said CEO Joshua Levine.

ShowHide Related Items >><<
ARAY Accuray
$5.51 /

+0.14 (+2.61%)

ARAY Accuray
$5.51 /

+0.14 (+2.61%)

10/26/21 Lake Street
Investors should buy Accuray after 'excellent' ASTRO meeting, says Lake Street
01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
ARAY Accuray
$5.51 /

+0.14 (+2.61%)

Over a month ago
Conference/Events
American Society for Radiation Oncology to hold annual meeting » 04:55
10/27/21
10/27
04:55
10/27/21
04:55
ARAY

Accuray

$4.31 /

-0.08 (-1.82%)

, NVS

Novartis

$84.84 /

+1.49 (+1.79%)

, AZN

AstraZeneca

$62.29 /

+0.54 (+0.87%)

, BAYRY

Bayer

$14.20 /

+0.04 (+0.28%)

, BD

Budget Group

/

+

, BIOC

Biocept

$3.76 /

-0.08 (-2.08%)

, BSX

Boston Scientific

$44.32 /

-0.17 (-0.38%)

, BMY

Bristol-Myers

$58.24 /

+0.47 (+0.81%)

, EKTAY

Elekta

$11.58 /

+0.09 (+0.78%)

, GRTX

Galera Therapeutics

$1.88 /

+0.04 (+2.17%)

, DNA

Ginkgo Bioworks

$14.46 /

+0.19 (+1.33%)

, HTHIY

Hitachi

$118.77 /

-0.71 (-0.59%)

, MRK

Merck

$82.23 /

+0.545 (+0.67%)

, MYGN

Myriad Genetics

$30.66 /

-1.81 (-5.57%)

, NBTX

Nanobiotix

$12.35 /

-0.3 (-2.37%)

, NNOX

Nano-X Imaging

$22.54 /

-0.55 (-2.38%)

, NTRA

Natera

$115.95 /

+0.2 (+0.17%)

, NVCR

Novocure

$113.51 /

-5.91 (-4.95%)

, PHG

Philips

$47.69 /

-0.12 (-0.25%)

, REGN

Regeneron

$592.37 /

+16.45 (+2.86%)

, SNY

Sanofi

$49.98 /

+0.125 (+0.25%)

, SGEN

Seagen

$177.70 /

+2.29 (+1.31%)

, SMMNY

Siemens Healthineers

$34.66 /

-0.07 (-0.20%)

, SYK

Stryker

$273.25 /

+0.08 (+0.03%)

, TDY

Teledyne

$437.11 /

-7.89 (-1.77%)

, VRAY

ViewRay

$6.96 /

-0.05 (-0.71%)

, VREX

Varex Imaging

$26.36 /

-0.7 (-2.59%)

63rd Annual ASTRO Meeting…

63rd Annual ASTRO Meeting 2021 will be held in Chicago on October 24-27.Webcast Link

ShowHide Related Items >><<
VRAY ViewRay
$6.96 /

-0.05 (-0.71%)

TDY Teledyne
$437.11 /

-7.89 (-1.77%)

SYK Stryker
$273.25 /

+0.08 (+0.03%)

SNY Sanofi
$49.98 /

+0.125 (+0.25%)

SMMNY Siemens Healthineers
$34.66 /

-0.07 (-0.20%)

SGEN Seagen
$177.70 /

+2.29 (+1.31%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

NVCR Novocure
$113.51 /

-5.91 (-4.95%)

NTRA Natera
$115.95 /

+0.2 (+0.17%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

NBTX Nanobiotix
$12.35 /

-0.3 (-2.37%)

MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

HTHIY Hitachi
$118.77 /

-0.71 (-0.59%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

EKTAY Elekta
$11.58 /

+0.09 (+0.78%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BIOC Biocept
$3.76 /

-0.08 (-2.08%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

ARAY Accuray
$4.31 /

-0.08 (-1.82%)

ARAY Accuray
$4.31 /

-0.08 (-1.82%)

10/26/21 Lake Street
Investors should buy Accuray after 'excellent' ASTRO meeting, says Lake Street
01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
NVS Novartis
$84.84 /

+1.49 (+1.79%)

10/12/21 Berenberg
Novartis price target lowered to CHF 88 from CHF 96 at Berenberg
10/08/21 UBS
Novartis price target lowered to CHF 92 from CHF 95 at UBS
09/29/21 Stifel
Blueprint Medicines rersumed with a Hold at Stifel
09/20/21 Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

10/19/21 UBS
AstraZeneca price target raised to 10,000 GBp from 9,200 GBp at UBS
10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

10/21/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
08/09/21 Berenberg
Bayer price target lowered to EUR 60 from EUR 74 at Berenberg
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
BD Budget Group
/

+

BIOC Biocept
$3.76 /

-0.08 (-2.08%)

10/08/21 Brookline
Biocept assumed with a Buy at Brookline
BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

10/06/21 Piper Sandler
Boston Scientific acquisition of Baylis looks 'solid,' says Piper Sandler
09/22/21 Piper Sandler
Boston Scientific said unlikely to hit low end of Q3 sales outlook, notes Piper
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

10/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $34 from $23 at RBC Capital
10/25/21 SVB Leerink
Potential Bristol takeover of Aurinia makes strategic sense, says SVB Leerink
10/25/21 Citi
Bristol-Myers report of Aurinia approach 'looks credible,' says Citi
10/12/21 Morgan Stanley
Bristol-Myers price target lowered to $66 from $71 at Morgan Stanley
EKTAY Elekta
$11.58 /

+0.09 (+0.78%)

08/27/21 JPMorgan
Elekta price target raised to SEK 95 from SEK 91 at JPMorgan
06/02/21 JPMorgan
Elekta price target raised to SEK 91 from SEK 82 at JPMorgan
04/27/21 JPMorgan
Elekta price target raised to SEK 82 from SEK 80 at JPMorgan
03/18/21 JPMorgan
Elekta downgraded to Underweight from Neutral at JPMorgan
GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

10/21/21 Citi
Galera Therapeutics price target lowered to $11 from $21 at Citi
10/20/21 H.C. Wainwright
Galera Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/19/21 BofA
Galera double downgraded to Underperform at BofA after ROMAN trial miss
10/19/21 BofA
Galera Therapeutics downgraded to Underperform from Buy at BofA
DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

10/20/21 Raymond James
Raymond James expects more equity-based payments for Ginkgo as milestones met
10/13/21 Raymond James
Ginkgo Bioworks initiated with an Outperform at Raymond James
10/12/21 William Blair
Blair starts Ginkgo at Outperform on 'significant' competitive advantage
10/12/21 William Blair
Ginkgo Bioworks initiated with an Outperform at William Blair
HTHIY Hitachi
$118.77 /

-0.71 (-0.59%)

11/20/20 Goldman Sachs
Hitachi reinstated with a Sell at Goldman Sachs
MRK Merck
$82.23 /

+0.545 (+0.67%)

10/22/21 SVB Leerink
Merck price target raised to $105 from $104 at SVB Leerink
10/19/21 Roth Capital
Enanta drug 'naturally more potent' than Merck's antiviral, says Roth Capital
10/19/21 Evercore ISI
Atea's Phase 2 design disappoints, but drug has not failed, says Evercore ISI
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

10/14/21 Cowen
Myriad Genetics coverage transferred at Cowen
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Myriad Genetics initiated with a Market Perform at Raymond James
06/03/21 Goldman Sachs
Myriad Genetics initiated with a Sell at Goldman Sachs
NBTX Nanobiotix
$12.35 /

-0.3 (-2.37%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

04/19/21 Ladenburg
Ladenburg starts Nano-X Imaging at Buy with $52 price target
04/19/21 Ladenburg
Nano-X Imaging initiated with a Buy at Ladenburg
02/01/21 Cantor Fitzgerald
Cantor Fitzgerald reiterates Overweight on Nano-X Imaging, lowers target to $67
NTRA Natera
$115.95 /

+0.2 (+0.17%)

10/19/21 Canaccord
Natera Prospera Lung launch to continue momentum, says Canaccord
10/14/21 Cowen
Natera coverage transferred at Cowen
08/31/21 Craig-Hallum
Natera seeks to challenge CareDx franchise with launch, says Craig-Hallum
08/09/21 Piper Sandler
Natera price target raised to $160 from $155 at Piper Sandler
NVCR Novocure
$113.51 /

-5.91 (-4.95%)

10/25/21 Piper Sandler
Novocure price target lowered to $195 from $235 at Piper Sandler
09/21/21 Piper Sandler
Novocure clinical update should come in next few weeks, says Piper Sandler
07/30/21 Mizuho
Novocure price target lowered to $200 from $229 at Mizuho
PHG Philips
$47.69 /

-0.12 (-0.25%)

10/25/21 Credit Suisse
Philips price target lowered to EUR 42 from EUR 49 at Credit Suisse
10/19/21 JPMorgan
Philips price target lowered to EUR 36.40 from EUR 40.90 at JPMorgan
10/19/21 Deutsche Bank
Philips price target lowered to EUR 42 from EUR 43 at Deutsche Bank
09/10/21 Barclays
Philips price target lowered to EUR 53 from EUR 54 at Barclays
REGN Regeneron
$592.37 /

+16.45 (+2.86%)

10/26/21 SVB Leerink
Regeneron price target raised to $798 from $785 at SVB Leerink
10/25/21 H.C. Wainwright
Regeneron trial data reinforce bullish outlook on Dupixent, says H.C. Wainwright
10/22/21 H.C. Wainwright
Regeneron price target raised to $842 from $831 at H.C. Wainwright
10/14/21 H.C. Wainwright
H.C. Wainwright 'enthusiastic' on Regeneron, sees no barrier for REGEN-COV nod
SNY Sanofi
$49.98 /

+0.125 (+0.25%)

10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
SGEN Seagen
$177.70 /

+2.29 (+1.31%)

10/14/21 BTIG
Seagen assumed with a Neutral at BTIG
09/27/21 RBC Capital
Seagen price target raised to $154 from $148 at RBC Capital
05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
SMMNY Siemens Healthineers
$34.66 /

-0.07 (-0.20%)

10/13/21 UBS
Siemens Healthineers price target raised to EUR 54 from EUR 48 at UBS
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold at Societe Generale
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold from Buy at Societe Generale
09/10/21 Barclays
Siemens Healthineers price target raised to EUR 55 from EUR 49 at Barclays
SYK Stryker
$273.25 /

+0.08 (+0.03%)

09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 SVB Leerink
Stryker price target raised to $300 from $290 at SVB Leerink
TDY Teledyne
$437.11 /

-7.89 (-1.77%)

07/30/21 Cowen
Teledyne price target raised to $525 from $500 at Cowen
06/08/21 Goldman Sachs
Teledyne reinstated with a Neutral at Goldman Sachs
05/25/21 BofA
Teledyne initiated with a Buy at BofA
04/29/21 Needham
Teledyne price target raised to $500 from $416 at Needham
VRAY ViewRay
$6.96 /

-0.05 (-0.71%)

10/19/21 Piper Sandler
ViewRay strength attributed to MIRAGE study recruiting halt, says Piper Sandler
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
06/25/21 Morgan Stanley
ViewRay upgraded to Equal Weight from Underweight at Morgan Stanley
VREX Varex Imaging
$26.36 /

-0.7 (-2.59%)

02/05/21 Oppenheimer
Varex Imaging upgraded to Outperform from Perform at Oppenheimer
VREX Varex Imaging
$26.36 /

-0.7 (-2.59%)

VRAY ViewRay
$6.96 /

-0.05 (-0.71%)

TDY Teledyne
$437.11 /

-7.89 (-1.77%)

SYK Stryker
$273.25 /

+0.08 (+0.03%)

SNY Sanofi
$49.98 /

+0.125 (+0.25%)

SGEN Seagen
$177.70 /

+2.29 (+1.31%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

NVCR Novocure
$113.51 /

-5.91 (-4.95%)

NTRA Natera
$115.95 /

+0.2 (+0.17%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

NBTX Nanobiotix
$12.35 /

-0.3 (-2.37%)

MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BIOC Biocept
$3.76 /

-0.08 (-2.08%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

ARAY Accuray
$4.31 /

-0.08 (-1.82%)

  • 22
    Jul
  • 11
    Feb
  • 22
    Jan
  • 05
    Jan
  • 11
    Dec
SNY Sanofi
$49.98 /

+0.125 (+0.25%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

HTHIY Hitachi
$118.77 /

-0.71 (-0.59%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

VREX Varex Imaging
$26.36 /

-0.7 (-2.59%)

SYK Stryker
$273.25 /

+0.08 (+0.03%)

SNY Sanofi
$49.98 /

+0.125 (+0.25%)

SMMNY Siemens Healthineers
$34.66 /

-0.07 (-0.20%)

SGEN Seagen
$177.70 /

+2.29 (+1.31%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

NVCR Novocure
$113.51 /

-5.91 (-4.95%)

NTRA Natera
$115.95 /

+0.2 (+0.17%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

TDY Teledyne
$437.11 /

-7.89 (-1.77%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

Recommendations
Investors should buy Accuray after 'excellent' ASTRO meeting, says Lake Street » 09:01
10/26/21
10/26
09:01
10/26/21
09:01
ARAY

Accuray

$4.39 /

+0.02 (+0.46%)

After having attended an…

After having attended an investor meeting with Accuray at the ASTRO medical event in Chicago that Lake Street analyst Brooks O'Neil called "excellent," he said he sees all the pieces in place for significant outperformance and that he detects an inflection point in performance that is not yet reflected in the stock. The analyst, who adds that in a "market many consider expensive, [Accuray] shares are silly cheap," said he would "buy this stock today" and affirms a Buy rating and $10 price target on the stock.

ShowHide Related Items >><<
ARAY Accuray
$4.39 /

+0.02 (+0.46%)

ARAY Accuray
$4.39 /

+0.02 (+0.46%)

01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
ARAY Accuray
$4.39 /

+0.02 (+0.46%)

Conference/Events
American Society for Radiation Oncology to hold annual meeting » 04:55
10/26/21
10/26
04:55
10/26/21
04:55
ARAY

Accuray

$4.39 /

+0.02 (+0.46%)

, NVS

Novartis

$83.37 /

-1.515 (-1.78%)

, AZN

AstraZeneca

$61.75 /

-0.06 (-0.10%)

, BAYRY

Bayer

$14.16 /

+0.025 (+0.18%)

, BD

Budget Group

/

+

, BIOC

Biocept

$3.84 /

-0.02 (-0.52%)

, BSX

Boston Scientific

$44.49 /

-0.355 (-0.79%)

, BMY

Bristol-Myers

$57.84 /

+0.25 (+0.43%)

, EKTAY

Elekta

$11.49 /

-0.14 (-1.20%)

, GRTX

Galera Therapeutics

$1.84 /

+0.02 (+1.10%)

, DNA

Ginkgo Bioworks

$14.27 /

+1.145 (+8.72%)

, HTHIY

Hitachi

$119.48 /

+1.76 (+1.50%)

, MRK

Merck

$81.68 /

+0.52 (+0.64%)

, MYGN

Myriad Genetics

$32.47 /

+0.03 (+0.09%)

, NBTX

Nanobiotix

$12.35 /

-0.7 (-5.36%)

, NNOX

Nano-X Imaging

$23.08 /

+0.345 (+1.52%)

, NTRA

Natera

$115.78 /

+0.82 (+0.71%)

, NVCR

Novocure

$119.37 /

-1.5 (-1.24%)

, PHG

Philips

$47.81 /

-0.3 (-0.62%)

, REGN

Regeneron

$576.15 /

+3.42 (+0.60%)

, SNY

Sanofi

$49.85 /

+ (+0.00%)

, SGEN

Seagen

$175.45 /

+4.14 (+2.42%)

, SMMNY

Siemens Healthineers

$34.73 /

+0.342 (+0.99%)

, SYK

Stryker

$273.17 /

-2.71 (-0.98%)

, TDY

Teledyne

$444.97 /

-1.14 (-0.26%)

, VRAY

ViewRay

$7.01 /

+0.205 (+3.01%)

, VREX

Varex Imaging

$27.05 /

+0.12 (+0.45%)

63rd Annual ASTRO Meeting…

63rd Annual ASTRO Meeting 2021 will be held in Chicago on October 24-27.Webcast Link

ShowHide Related Items >><<
VRAY ViewRay
$7.01 /

+0.205 (+3.01%)

TDY Teledyne
$444.97 /

-1.14 (-0.26%)

SYK Stryker
$273.17 /

-2.71 (-0.98%)

SNY Sanofi
$49.85 /

+ (+0.00%)

SMMNY Siemens Healthineers
$34.73 /

+0.342 (+0.99%)

SGEN Seagen
$175.45 /

+4.14 (+2.42%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

PHG Philips
$47.81 /

-0.3 (-0.62%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

NVCR Novocure
$119.37 /

-1.5 (-1.24%)

NTRA Natera
$115.78 /

+0.82 (+0.71%)

NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

NBTX Nanobiotix
$12.35 /

-0.7 (-5.36%)

MYGN Myriad Genetics
$32.47 /

+0.03 (+0.09%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

HTHIY Hitachi
$119.48 /

+1.76 (+1.50%)

GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

EKTAY Elekta
$11.49 /

-0.14 (-1.20%)

DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

BIOC Biocept
$3.84 /

-0.02 (-0.52%)

BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

ARAY Accuray
$4.39 /

+0.02 (+0.46%)

ARAY Accuray
$4.39 /

+0.02 (+0.46%)

01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
NVS Novartis
$83.37 /

-1.515 (-1.78%)

10/12/21 Berenberg
Novartis price target lowered to CHF 88 from CHF 96 at Berenberg
10/08/21 UBS
Novartis price target lowered to CHF 92 from CHF 95 at UBS
09/29/21 Stifel
Blueprint Medicines rersumed with a Hold at Stifel
09/20/21 Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

10/19/21 UBS
AstraZeneca price target raised to 10,000 GBp from 9,200 GBp at UBS
10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

10/21/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
08/09/21 Berenberg
Bayer price target lowered to EUR 60 from EUR 74 at Berenberg
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
BD Budget Group
/

+

BIOC Biocept
$3.84 /

-0.02 (-0.52%)

10/08/21 Brookline
Biocept assumed with a Buy at Brookline
BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

10/06/21 Piper Sandler
Boston Scientific acquisition of Baylis looks 'solid,' says Piper Sandler
09/22/21 Piper Sandler
Boston Scientific said unlikely to hit low end of Q3 sales outlook, notes Piper
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

10/25/21 SVB Leerink
Potential Bristol takeover of Aurinia makes strategic sense, says SVB Leerink
10/25/21 Citi
Bristol-Myers report of Aurinia approach 'looks credible,' says Citi
10/12/21 Morgan Stanley
Bristol-Myers price target lowered to $66 from $71 at Morgan Stanley
10/08/21 Morgan Stanley
Bristol-Myers' UC trial miss an incremental negative, says Morgan Stanley
EKTAY Elekta
$11.49 /

-0.14 (-1.20%)

08/27/21 JPMorgan
Elekta price target raised to SEK 95 from SEK 91 at JPMorgan
06/02/21 JPMorgan
Elekta price target raised to SEK 91 from SEK 82 at JPMorgan
04/27/21 JPMorgan
Elekta price target raised to SEK 82 from SEK 80 at JPMorgan
03/18/21 JPMorgan
Elekta downgraded to Underweight from Neutral at JPMorgan
GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

10/21/21 Citi
Galera Therapeutics price target lowered to $11 from $21 at Citi
10/20/21 H.C. Wainwright
Galera Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/19/21 BofA
Galera double downgraded to Underperform at BofA after ROMAN trial miss
10/19/21 BofA
Galera Therapeutics downgraded to Underperform from Buy at BofA
DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

10/20/21 Raymond James
Raymond James expects more equity-based payments for Ginkgo as milestones met
10/13/21 Raymond James
Ginkgo Bioworks initiated with an Outperform at Raymond James
10/12/21 William Blair
Blair starts Ginkgo at Outperform on 'significant' competitive advantage
10/12/21 William Blair
Ginkgo Bioworks initiated with an Outperform at William Blair
HTHIY Hitachi
$119.48 /

+1.76 (+1.50%)

11/20/20 Goldman Sachs
Hitachi reinstated with a Sell at Goldman Sachs
MRK Merck
$81.68 /

+0.52 (+0.64%)

10/22/21 SVB Leerink
Merck price target raised to $105 from $104 at SVB Leerink
10/19/21 Roth Capital
Enanta drug 'naturally more potent' than Merck's antiviral, says Roth Capital
10/19/21 Evercore ISI
Atea's Phase 2 design disappoints, but drug has not failed, says Evercore ISI
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
MYGN Myriad Genetics
$32.47 /

+0.03 (+0.09%)

10/14/21 Cowen
Myriad Genetics coverage transferred at Cowen
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Myriad Genetics initiated with a Market Perform at Raymond James
06/03/21 Goldman Sachs
Myriad Genetics initiated with a Sell at Goldman Sachs
NBTX Nanobiotix
$12.35 /

-0.7 (-5.36%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

04/19/21 Ladenburg
Ladenburg starts Nano-X Imaging at Buy with $52 price target
04/19/21 Ladenburg
Nano-X Imaging initiated with a Buy at Ladenburg
02/01/21 Cantor Fitzgerald
Cantor Fitzgerald reiterates Overweight on Nano-X Imaging, lowers target to $67
NTRA Natera
$115.78 /

+0.82 (+0.71%)

10/19/21 Canaccord
Natera Prospera Lung launch to continue momentum, says Canaccord
10/14/21 Cowen
Natera coverage transferred at Cowen
08/31/21 Craig-Hallum
Natera seeks to challenge CareDx franchise with launch, says Craig-Hallum
08/09/21 Piper Sandler
Natera price target raised to $160 from $155 at Piper Sandler
NVCR Novocure
$119.37 /

-1.5 (-1.24%)

10/25/21 Piper Sandler
Novocure price target lowered to $195 from $235 at Piper Sandler
09/21/21 Piper Sandler
Novocure clinical update should come in next few weeks, says Piper Sandler
07/30/21 Mizuho
Novocure price target lowered to $200 from $229 at Mizuho
PHG Philips
$47.81 /

-0.3 (-0.62%)

10/25/21 Credit Suisse
Philips price target lowered to EUR 42 from EUR 49 at Credit Suisse
10/19/21 JPMorgan
Philips price target lowered to EUR 36.40 from EUR 40.90 at JPMorgan
10/19/21 Deutsche Bank
Philips price target lowered to EUR 42 from EUR 43 at Deutsche Bank
09/10/21 Barclays
Philips price target lowered to EUR 53 from EUR 54 at Barclays
REGN Regeneron
$576.15 /

+3.42 (+0.60%)

10/25/21 H.C. Wainwright
Regeneron trial data reinforce bullish outlook on Dupixent, says H.C. Wainwright
10/22/21 H.C. Wainwright
Regeneron price target raised to $842 from $831 at H.C. Wainwright
10/14/21 H.C. Wainwright
H.C. Wainwright 'enthusiastic' on Regeneron, sees no barrier for REGEN-COV nod
10/04/21 Piper Sandler
Amgen's AMG 451 looks competitive with Dupixent, says Piper Sandler
SNY Sanofi
$49.85 /

+ (+0.00%)

10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
SGEN Seagen
$175.45 /

+4.14 (+2.42%)

10/14/21 BTIG
Seagen assumed with a Neutral at BTIG
09/27/21 RBC Capital
Seagen price target raised to $154 from $148 at RBC Capital
05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
SMMNY Siemens Healthineers
$34.73 /

+0.342 (+0.99%)

10/13/21 UBS
Siemens Healthineers price target raised to EUR 54 from EUR 48 at UBS
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold at Societe Generale
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold from Buy at Societe Generale
09/10/21 Barclays
Siemens Healthineers price target raised to EUR 55 from EUR 49 at Barclays
SYK Stryker
$273.17 /

-2.71 (-0.98%)

09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 SVB Leerink
Stryker price target raised to $300 from $290 at SVB Leerink
TDY Teledyne
$444.97 /

-1.14 (-0.26%)

07/30/21 Cowen
Teledyne price target raised to $525 from $500 at Cowen
06/08/21 Goldman Sachs
Teledyne reinstated with a Neutral at Goldman Sachs
05/25/21 BofA
Teledyne initiated with a Buy at BofA
04/29/21 Needham
Teledyne price target raised to $500 from $416 at Needham
VRAY ViewRay
$7.01 /

+0.205 (+3.01%)

10/19/21 Piper Sandler
ViewRay strength attributed to MIRAGE study recruiting halt, says Piper Sandler
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
06/25/21 Morgan Stanley
ViewRay upgraded to Equal Weight from Underweight at Morgan Stanley
VREX Varex Imaging
$27.05 /

+0.12 (+0.45%)

02/05/21 Oppenheimer
Varex Imaging upgraded to Outperform from Perform at Oppenheimer
VREX Varex Imaging
$27.05 /

+0.12 (+0.45%)

VRAY ViewRay
$7.01 /

+0.205 (+3.01%)

TDY Teledyne
$444.97 /

-1.14 (-0.26%)

SYK Stryker
$273.17 /

-2.71 (-0.98%)

SNY Sanofi
$49.85 /

+ (+0.00%)

SGEN Seagen
$175.45 /

+4.14 (+2.42%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

PHG Philips
$47.81 /

-0.3 (-0.62%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

NVCR Novocure
$119.37 /

-1.5 (-1.24%)

NTRA Natera
$115.78 /

+0.82 (+0.71%)

NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

NBTX Nanobiotix
$12.35 /

-0.7 (-5.36%)

MYGN Myriad Genetics
$32.47 /

+0.03 (+0.09%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

BIOC Biocept
$3.84 /

-0.02 (-0.52%)

BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

ARAY Accuray
$4.39 /

+0.02 (+0.46%)

  • 22
    Jul
  • 11
    Feb
  • 22
    Jan
  • 05
    Jan
  • 11
    Dec
SNY Sanofi
$49.85 /

+ (+0.00%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

PHG Philips
$47.81 /

-0.3 (-0.62%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

HTHIY Hitachi
$119.48 /

+1.76 (+1.50%)

DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

VREX Varex Imaging
$27.05 /

+0.12 (+0.45%)

SYK Stryker
$273.17 /

-2.71 (-0.98%)

SNY Sanofi
$49.85 /

+ (+0.00%)

SMMNY Siemens Healthineers
$34.73 /

+0.342 (+0.99%)

SGEN Seagen
$175.45 /

+4.14 (+2.42%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

PHG Philips
$47.81 /

-0.3 (-0.62%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

NVCR Novocure
$119.37 /

-1.5 (-1.24%)

NTRA Natera
$115.78 /

+0.82 (+0.71%)

NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

MYGN Myriad Genetics
$32.47 /

+0.03 (+0.09%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

TDY Teledyne
$444.97 /

-1.14 (-0.26%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

Conference/Events
American Society for Radiation Oncology to hold annual meeting » 08:46
10/25/21
10/25
08:46
10/25/21
08:46
ARAY

Accuray

$4.37 /

+0.3 (+7.37%)

, NVS

Novartis

$84.88 /

+0.2 (+0.24%)

, AZN

AstraZeneca

$61.81 /

+0.62 (+1.01%)

, BAYRY

Bayer

$14.13 /

+0.04 (+0.28%)

, BD

Budget Group

/

+

, BIOC

Biocept

$3.85 /

-0.09 (-2.28%)

, BSX

Boston Scientific

$44.85 /

-0.045 (-0.10%)

, BMY

Bristol-Myers

$57.59 /

-0.225 (-0.39%)

, EKTAY

Elekta

$11.63 /

+0.29 (+2.56%)

, GRTX

Galera Therapeutics

$1.83 /

-0.185 (-9.20%)

, DNA

Ginkgo Bioworks

$13.13 /

-0.08 (-0.61%)

, HTHIY

Hitachi

$117.72 /

+0.79 (+0.68%)

, MRK

Merck

$81.16 /

-0.01 (-0.01%)

, MYGN

Myriad Genetics

$32.49 /

-0.005 (-0.02%)

, NBTX

Nanobiotix

$13.05 /

+ (+0.00%)

, NNOX

Nano-X Imaging

$22.72 /

-1.01 (-4.26%)

, NTRA

Natera

$114.98 /

+2.56 (+2.28%)

, NVCR

Novocure

$120.88 /

-1.28 (-1.05%)

, PHG

Philips

$48.11 /

+0.6 (+1.26%)

, REGN

Regeneron

$572.62 /

+3.73 (+0.66%)

, SNY

Sanofi

$49.87 /

+0.67 (+1.36%)

, SGEN

Seagen

$171.55 /

-2.33 (-1.34%)

, SMMNY

Siemens Healthineers

$34.39 /

+0.238 (+0.70%)

, SYK

Stryker

$275.78 /

-0.69 (-0.25%)

, TDY

Teledyne

$446.11 /

+2.415 (+0.54%)

, VRAY

ViewRay

$6.81 /

+0.075 (+1.11%)

, VREX

Varex Imaging

$26.93 /

+0.15 (+0.56%)

63rd Annual ASTRO Meeting…

63rd Annual ASTRO Meeting 2021 will be held in Chicago on October 24-27.Webcast Link

ShowHide Related Items >><<
VRAY ViewRay
$6.81 /

+0.075 (+1.11%)

TDY Teledyne
$446.11 /

+2.415 (+0.54%)

SYK Stryker
$275.78 /

-0.69 (-0.25%)

SNY Sanofi
$49.87 /

+0.67 (+1.36%)

SMMNY Siemens Healthineers
$34.39 /

+0.238 (+0.70%)

SGEN Seagen
$171.55 /

-2.33 (-1.34%)

REGN Regeneron
$572.62 /

+3.73 (+0.66%)

PHG Philips
$48.11 /

+0.6 (+1.26%)

NVS Novartis
$84.88 /

+0.2 (+0.24%)

NVCR Novocure
$120.88 /

-1.28 (-1.05%)

NTRA Natera
$114.98 /

+2.56 (+2.28%)

NNOX Nano-X Imaging
$22.72 /

-1.01 (-4.26%)

NBTX Nanobiotix
$13.05 /

+ (+0.00%)

MYGN Myriad Genetics
$32.49 /

-0.005 (-0.02%)

MRK Merck
$81.16 /

-0.01 (-0.01%)

HTHIY Hitachi
$117.72 /

+0.79 (+0.68%)

GRTX Galera Therapeutics
$1.83 /

-0.185 (-9.20%)

EKTAY Elekta
$11.63 /

+0.29 (+2.56%)

DNA Ginkgo Bioworks
$13.13 /

-0.08 (-0.61%)

BSX Boston Scientific
$44.85 /

-0.045 (-0.10%)

BMY Bristol-Myers
$57.59 /

-0.225 (-0.39%)

BIOC Biocept
$3.85 /

-0.09 (-2.28%)

BAYRY Bayer
$14.13 /

+0.04 (+0.28%)

AZN AstraZeneca
$61.81 /

+0.62 (+1.01%)

ARAY Accuray
$4.37 /

+0.3 (+7.37%)

ARAY Accuray
$4.37 /

+0.3 (+7.37%)

01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
NVS Novartis
$84.88 /

+0.2 (+0.24%)

10/12/21 Berenberg
Novartis price target lowered to CHF 88 from CHF 96 at Berenberg
10/08/21 UBS
Novartis price target lowered to CHF 92 from CHF 95 at UBS
09/29/21 Stifel
Blueprint Medicines rersumed with a Hold at Stifel
09/20/21 Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
AZN AstraZeneca
$61.81 /

+0.62 (+1.01%)

10/19/21 UBS
AstraZeneca price target raised to 10,000 GBp from 9,200 GBp at UBS
10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
BAYRY Bayer
$14.13 /

+0.04 (+0.28%)

10/21/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
08/09/21 Berenberg
Bayer price target lowered to EUR 60 from EUR 74 at Berenberg
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
BD Budget Group
/

+

BIOC Biocept
$3.85 /

-0.09 (-2.28%)

10/08/21 Brookline
Biocept assumed with a Buy at Brookline
BSX Boston Scientific
$44.85 /

-0.045 (-0.10%)

10/06/21 Piper Sandler
Boston Scientific acquisition of Baylis looks 'solid,' says Piper Sandler
09/22/21 Piper Sandler
Boston Scientific said unlikely to hit low end of Q3 sales outlook, notes Piper
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
BMY Bristol-Myers
$57.59 /

-0.225 (-0.39%)

10/25/21 Citi
Bristol-Myers report of Aurinia approach 'looks credible,' says Citi
10/12/21 Morgan Stanley
Bristol-Myers price target lowered to $66 from $71 at Morgan Stanley
10/08/21 Morgan Stanley
Bristol-Myers' UC trial miss an incremental negative, says Morgan Stanley
10/08/21 Barclays
Bristol-Myers price target lowered to $68 from $71 at Barclays
EKTAY Elekta
$11.63 /

+0.29 (+2.56%)

08/27/21 JPMorgan
Elekta price target raised to SEK 95 from SEK 91 at JPMorgan
06/02/21 JPMorgan
Elekta price target raised to SEK 91 from SEK 82 at JPMorgan
04/27/21 JPMorgan
Elekta price target raised to SEK 82 from SEK 80 at JPMorgan
03/18/21 JPMorgan
Elekta downgraded to Underweight from Neutral at JPMorgan
GRTX Galera Therapeutics
$1.83 /

-0.185 (-9.20%)

10/21/21 Citi
Galera Therapeutics price target lowered to $11 from $21 at Citi
10/20/21 H.C. Wainwright
Galera Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/19/21 BofA
Galera double downgraded to Underperform at BofA after ROMAN trial miss
10/19/21 BofA
Galera Therapeutics downgraded to Underperform from Buy at BofA
DNA Ginkgo Bioworks
$13.13 /

-0.08 (-0.61%)

10/20/21 Raymond James
Raymond James expects more equity-based payments for Ginkgo as milestones met
10/13/21 Raymond James
Ginkgo Bioworks initiated with an Outperform at Raymond James
10/12/21 William Blair
Blair starts Ginkgo at Outperform on 'significant' competitive advantage
10/12/21 William Blair
Ginkgo Bioworks initiated with an Outperform at William Blair
HTHIY Hitachi
$117.72 /

+0.79 (+0.68%)

11/20/20 Goldman Sachs
Hitachi reinstated with a Sell at Goldman Sachs
MRK Merck
$81.16 /

-0.01 (-0.01%)

10/22/21 SVB Leerink
Merck price target raised to $105 from $104 at SVB Leerink
10/19/21 Roth Capital
Enanta drug 'naturally more potent' than Merck's antiviral, says Roth Capital
10/19/21 Evercore ISI
Atea's Phase 2 design disappoints, but drug has not failed, says Evercore ISI
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
MYGN Myriad Genetics
$32.49 /

-0.005 (-0.02%)

10/14/21 Cowen
Myriad Genetics coverage transferred at Cowen
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Myriad Genetics initiated with a Market Perform at Raymond James
06/03/21 Goldman Sachs
Myriad Genetics initiated with a Sell at Goldman Sachs
NBTX Nanobiotix
$13.05 /

+ (+0.00%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
NNOX Nano-X Imaging
$22.72 /

-1.01 (-4.26%)

04/19/21 Ladenburg
Ladenburg starts Nano-X Imaging at Buy with $52 price target
04/19/21 Ladenburg
Nano-X Imaging initiated with a Buy at Ladenburg
02/01/21 Cantor Fitzgerald
Cantor Fitzgerald reiterates Overweight on Nano-X Imaging, lowers target to $67
NTRA Natera
$114.98 /

+2.56 (+2.28%)

10/19/21 Canaccord
Natera Prospera Lung launch to continue momentum, says Canaccord
10/14/21 Cowen
Natera coverage transferred at Cowen
08/31/21 Craig-Hallum
Natera seeks to challenge CareDx franchise with launch, says Craig-Hallum
08/09/21 Piper Sandler
Natera price target raised to $160 from $155 at Piper Sandler
NVCR Novocure
$120.88 /

-1.28 (-1.05%)

10/25/21 Piper Sandler
Novocure price target lowered to $195 from $235 at Piper Sandler
09/21/21 Piper Sandler
Novocure clinical update should come in next few weeks, says Piper Sandler
07/30/21 Mizuho
Novocure price target lowered to $200 from $229 at Mizuho
PHG Philips
$48.11 /

+0.6 (+1.26%)

10/19/21 JPMorgan
Philips price target lowered to EUR 36.40 from EUR 40.90 at JPMorgan
10/19/21 Deutsche Bank
Philips price target lowered to EUR 42 from EUR 43 at Deutsche Bank
09/10/21 Barclays
Philips price target lowered to EUR 53 from EUR 54 at Barclays
09/08/21
Fly Intel: Top five analyst initiations
REGN Regeneron
$572.62 /

+3.73 (+0.66%)

10/22/21 H.C. Wainwright
Regeneron price target raised to $842 from $831 at H.C. Wainwright
10/14/21 H.C. Wainwright
H.C. Wainwright 'enthusiastic' on Regeneron, sees no barrier for REGEN-COV nod
10/04/21 Piper Sandler
Amgen's AMG 451 looks competitive with Dupixent, says Piper Sandler
10/04/21 H.C. Wainwright
Regeneron selloff brings 'excellent entry point,' says H.C. Wainwright
SNY Sanofi
$49.87 /

+0.67 (+1.36%)

10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
SGEN Seagen
$171.55 /

-2.33 (-1.34%)

10/14/21 BTIG
Seagen assumed with a Neutral at BTIG
09/27/21 RBC Capital
Seagen price target raised to $154 from $148 at RBC Capital
05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
SMMNY Siemens Healthineers
$34.39 /

+0.238 (+0.70%)

10/13/21 UBS
Siemens Healthineers price target raised to EUR 54 from EUR 48 at UBS
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold at Societe Generale
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold from Buy at Societe Generale
09/10/21 Barclays
Siemens Healthineers price target raised to EUR 55 from EUR 49 at Barclays
SYK Stryker
$275.78 /

-0.69 (-0.25%)

09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 SVB Leerink
Stryker price target raised to $300 from $290 at SVB Leerink
TDY Teledyne
$446.11 /

+2.415 (+0.54%)

07/30/21 Cowen
Teledyne price target raised to $525 from $500 at Cowen
06/08/21 Goldman Sachs
Teledyne reinstated with a Neutral at Goldman Sachs
05/25/21 BofA
Teledyne initiated with a Buy at BofA
04/29/21 Needham
Teledyne price target raised to $500 from $416 at Needham
VRAY ViewRay
$6.81 /

+0.075 (+1.11%)

10/19/21 Piper Sandler
ViewRay strength attributed to MIRAGE study recruiting halt, says Piper Sandler
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
06/25/21 Morgan Stanley
ViewRay upgraded to Equal Weight from Underweight at Morgan Stanley
VREX Varex Imaging
$26.93 /

+0.15 (+0.56%)

02/05/21 Oppenheimer
Varex Imaging upgraded to Outperform from Perform at Oppenheimer
VREX Varex Imaging
$26.93 /

+0.15 (+0.56%)

VRAY ViewRay
$6.81 /

+0.075 (+1.11%)

TDY Teledyne
$446.11 /

+2.415 (+0.54%)

SYK Stryker
$275.78 /

-0.69 (-0.25%)

SNY Sanofi
$49.87 /

+0.67 (+1.36%)

SGEN Seagen
$171.55 /

-2.33 (-1.34%)

REGN Regeneron
$572.62 /

+3.73 (+0.66%)

PHG Philips
$48.11 /

+0.6 (+1.26%)

NVS Novartis
$84.88 /

+0.2 (+0.24%)

NVCR Novocure
$120.88 /

-1.28 (-1.05%)

NTRA Natera
$114.98 /

+2.56 (+2.28%)

NNOX Nano-X Imaging
$22.72 /

-1.01 (-4.26%)

NBTX Nanobiotix
$13.05 /

+ (+0.00%)

MYGN Myriad Genetics
$32.49 /

-0.005 (-0.02%)

MRK Merck
$81.16 /

-0.01 (-0.01%)

GRTX Galera Therapeutics
$1.83 /

-0.185 (-9.20%)

BSX Boston Scientific
$44.85 /

-0.045 (-0.10%)

BMY Bristol-Myers
$57.59 /

-0.225 (-0.39%)

BIOC Biocept
$3.85 /

-0.09 (-2.28%)

BAYRY Bayer
$14.13 /

+0.04 (+0.28%)

AZN AstraZeneca
$61.81 /

+0.62 (+1.01%)

ARAY Accuray
$4.37 /

+0.3 (+7.37%)

  • 22
    Jul
  • 11
    Feb
  • 22
    Jan
  • 05
    Jan
  • 11
    Dec
SNY Sanofi
$49.87 /

+0.67 (+1.36%)

REGN Regeneron
$572.62 /

+3.73 (+0.66%)

PHG Philips
$48.11 /

+0.6 (+1.26%)

NVS Novartis
$84.88 /

+0.2 (+0.24%)

MRK Merck
$81.16 /

-0.01 (-0.01%)

HTHIY Hitachi
$117.72 /

+0.79 (+0.68%)

DNA Ginkgo Bioworks
$13.13 /

-0.08 (-0.61%)

BSX Boston Scientific
$44.85 /

-0.045 (-0.10%)

BMY Bristol-Myers
$57.59 /

-0.225 (-0.39%)

BAYRY Bayer
$14.13 /

+0.04 (+0.28%)

AZN AstraZeneca
$61.81 /

+0.62 (+1.01%)

VREX Varex Imaging
$26.93 /

+0.15 (+0.56%)

SYK Stryker
$275.78 /

-0.69 (-0.25%)

SNY Sanofi
$49.87 /

+0.67 (+1.36%)

SMMNY Siemens Healthineers
$34.39 /

+0.238 (+0.70%)

SGEN Seagen
$171.55 /

-2.33 (-1.34%)

REGN Regeneron
$572.62 /

+3.73 (+0.66%)

PHG Philips
$48.11 /

+0.6 (+1.26%)

NVS Novartis
$84.88 /

+0.2 (+0.24%)

NVCR Novocure
$120.88 /

-1.28 (-1.05%)

NTRA Natera
$114.98 /

+2.56 (+2.28%)

NNOX Nano-X Imaging
$22.72 /

-1.01 (-4.26%)

MYGN Myriad Genetics
$32.49 /

-0.005 (-0.02%)

MRK Merck
$81.16 /

-0.01 (-0.01%)

GRTX Galera Therapeutics
$1.83 /

-0.185 (-9.20%)

DNA Ginkgo Bioworks
$13.13 /

-0.08 (-0.61%)

BSX Boston Scientific
$44.85 /

-0.045 (-0.10%)

BMY Bristol-Myers
$57.59 /

-0.225 (-0.39%)

BAYRY Bayer
$14.13 /

+0.04 (+0.28%)

AZN AstraZeneca
$61.81 /

+0.62 (+1.01%)

TDY Teledyne
$446.11 /

+2.415 (+0.54%)

REGN Regeneron
$572.62 /

+3.73 (+0.66%)

NVS Novartis
$84.88 /

+0.2 (+0.24%)

NNOX Nano-X Imaging
$22.72 /

-1.01 (-4.26%)

MRK Merck
$81.16 /

-0.01 (-0.01%)

GRTX Galera Therapeutics
$1.83 /

-0.185 (-9.20%)

DNA Ginkgo Bioworks
$13.13 /

-0.08 (-0.61%)

BSX Boston Scientific
$44.85 /

-0.045 (-0.10%)

BMY Bristol-Myers
$57.59 /

-0.225 (-0.39%)

AZN AstraZeneca
$61.81 /

+0.62 (+1.01%)

Hot Stocks
Accuray's CyberKnife platform shows breast cancer survival improvement in study » 07:39
10/25/21
10/25
07:39
10/25/21
07:39
ARAY

Accuray

$4.37 /

+0.3 (+7.37%)

Accuray announced that a…

Accuray announced that a study published in Frontiers in Oncology found early-stage breast cancer patients could experience significant improvements in survival if treated with accelerated partial breast irradiation delivered using the Accuray CyberKnife robotic radiotherapy platform. Study investigators performed complex modeling that also indicates the survival rate could be better with CyberKnife APBI than other radiation delivery approaches. The CyberKnife platform is equipped with artificial intelligence-driven motion synchronization technology, Synchrony, that adjusts the radiation beam to the patient or tumor movement, keeping on target throughout the treatment, reducing patient burden.

ShowHide Related Items >><<
ARAY Accuray
$4.37 /

+0.3 (+7.37%)

ARAY Accuray
$4.37 /

+0.3 (+7.37%)

01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
ARAY Accuray
$4.37 /

+0.3 (+7.37%)

Conference/Events
Accuray to hold analyst & investor meeting » 00:00
10/25/21
10/25
00:00
10/25/21
00:00
ARAY

Accuray

$4.37 /

+0.3 (+7.37%)

Analyst & Investor…

Analyst & Investor Meeting being held in conjunction with the ASTRO Annual Meeting on October 25 at 4 pm. Webcast Link

ShowHide Related Items >><<
ARAY Accuray
$4.37 /

+0.3 (+7.37%)

ARAY Accuray
$4.37 /

+0.3 (+7.37%)

01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
ARAY Accuray
$4.37 /

+0.3 (+7.37%)

Earnings
Accuray raises FY22 revenue view to $420M-$427M from $410.0M-$420.0M » 16:08
10/21/21
10/21
16:08
10/21/21
16:08
ARAY

Accuray

$4.06 /

+0.08 (+2.01%)

Consensus for FY22…

Consensus for FY22 revenue is $415.82M.

ShowHide Related Items >><<
ARAY Accuray
$4.06 /

+0.08 (+2.01%)

ARAY Accuray
$4.06 /

+0.08 (+2.01%)

01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
ARAY Accuray
$4.06 /

+0.08 (+2.01%)

Earnings
Accuray sees Q1 revenue $107.4M, consensus $88.49M » 16:07
10/21/21
10/21
16:07
10/21/21
16:07
ARAY

Accuray

$4.06 /

+0.08 (+2.01%)

Sees Q1 GAAP net loss…

Sees Q1 GAAP net loss range of $2.0M-$1.0M. Sees Q1 Adjusted EBITDA range of $4.5M-$5.5M.

ShowHide Related Items >><<
ARAY Accuray
$4.06 /

+0.08 (+2.01%)

ARAY Accuray
$4.06 /

+0.08 (+2.01%)

01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
ARAY Accuray
$4.06 /

+0.08 (+2.01%)

Conference/Events
Accuray to hold analyst & investor meeting » 16:36
10/15/21
10/15
16:36
10/15/21
16:36
ARAY

Accuray

$3.94 /

+0.03 (+0.77%)

Analyst & Investor…

Analyst & Investor Meeting being held in conjunction with the ASTRO Annual Meeting on October 25 at 4 pm. Webcast Link

ShowHide Related Items >><<
ARAY Accuray
$3.94 /

+0.03 (+0.77%)

ARAY Accuray
$3.94 /

+0.03 (+0.77%)

01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
ARAY Accuray
$3.94 /

+0.03 (+0.77%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.